Working… Menu

C1q/TNF-related Proteins in Non-Alcoholic Fatty Liver Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02083159
Recruitment Status : Unknown
Verified September 2016 by Kyung Mook Choi, Korea University.
Recruitment status was:  Recruiting
First Posted : March 11, 2014
Last Update Posted : September 21, 2016
Information provided by (Responsible Party):
Kyung Mook Choi, Korea University

Brief Summary:

Non-alcoholic fatty liver disease (NAFLD) is characterized by an accumulation of fat in the liver, which is one of the most common forms of chronic liver disease in developed countries. In western countries, the prevalence of NAFLD in the general population is estimated to be 20-30%; in obese populations, this increases to 57.5-74%. But, it hasn't been clearly elucidated yet regarding the underlying disease pathophysiology and treatmet strategy.

Recently, members of the C1q/tumor necrosis factor-related protein (CTRP) family have been reported to share structural homology with adiponectin. To date, 15 CTRP family members have been found that might play major roles in glucose metabolism and inflammation.

The investigators tried to clarify the relationship between CTRP family and NAFLD in Korean men and women.

Condition or disease

Layout table for study information
Study Type : Observational
Estimated Enrollment : 500 participants
Observational Model: Cohort
Time Perspective: Prospective
Study Start Date : March 2012
Estimated Primary Completion Date : December 2016

Patients with NAFLD

Primary Outcome Measures :
  1. serum concentration of CTRP-1, 3, or 9 in the subjects with/without NAFLD [ Time Frame: at enrollment ]

Secondary Outcome Measures :
  1. The relationships of serum CTRPs/adiponectin levels with cardiometabolic risk profiles [ Time Frame: at enrollment ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   20 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
The subjects who visited for a routine health check-up at the Health Promotion Center of Korea University Guro Hospital were enrolled using predefined inclusion and exclusion criteria.

Inclusion Criteria:

  • 20<age<80
  • apparently healthy subjects

Exclusion Criteria:

  • a history of CVD
  • diabetes
  • stage 2 hypertension
  • malignancy
  • severe renal or hepatic disease

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT02083159

Layout table for location contacts
Contact: Ho Cheol Hong, M.D. 822-2626-3044
Contact: Kyung Mook Choi, M.D. 822-2626-3043

Layout table for location information
Korea, Republic of
Korea Univ. Guro Hospital Recruiting
Seoul, Korea, Republic of
Contact: Ho Cheol Hong, M.D.    822-2626-3044   
Contact: Kyung Mook Choi, M.D.    822-2626-3043   
Sponsors and Collaborators
Korea University
Layout table for additonal information
Responsible Party: Kyung Mook Choi, Professor, Korea University Identifier: NCT02083159    
Other Study ID Numbers: NAFLD(CTRP)
First Posted: March 11, 2014    Key Record Dates
Last Update Posted: September 21, 2016
Last Verified: September 2016